UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 5.

Parviainen, S; Ahonen, M; Diaconu, I; Kipar, A; Siurala, M; Vähä-Koskela, M; Kanerva, A; Cerullo, V; Hemminki, A (2015). GMCSF-armed vaccinia virus induces an antitumor immune response. International Journal of Cancer, 136(5):1065-1072.

Siurala, M; Bramante, S; Vassilev, L; Hirvinen, M; Parviainen, S; Tähtinen, S; Guse, K; Cerullo, V; Kanerva, A; Kipar, A; Vähä-Koskela, M; Hemminki, A (2015). Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. International Journal of Cancer, 136(4):945-954.

Bramante, S; Koski, A; Kipar, A; Diaconu, I; Liikanen, I; Hemminki, O; Vassilev, L; Parviainen, S; Cerullo, V; Pesonen, S K; Oksanen, M; Heiskanen, R; Rouvinen-Lagerström, N; Merisalo-Soikkeli, M; Hakonen, T; Joensuu, T; Kanerva, A; Pesonen, S; Hemminki, A (2014). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer, 135(3):720-730.

Koski, A; Karli, E; Kipar, A; Escutenaire, S; Kanerva, A; Hemminki, A (2013). Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism. PLoS ONE, 8(4):e60032.

Hemminki, O; Bauerschmitz, G; Hemmi, S; Lavilla-Alonso, S; Diaconu, I; Guse, K; Koski, A; Desmond, R A; Lappalainen, M; Kanerva, A; Cerullo, V; Pesonen, S; Hemminki, A (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy, 18:288-296.

This list was generated on Thu Jul 27 15:44:34 2017 CEST.